Invitation to Alligator Bioscience's Earnings Call on 26 August 2026
(PR-inside.com) LUND, SE / ACCESS Newswire / August 20, 2026 / Alligator Bioscience (STO:ATORX), a biotechnology company whose principal asset is a financial interest in the HER2-targeting antibody programme HLX22, will publish its interim report for April - June 2026 on Wednesday, 26 August 2026, at 8:00 a.m. CEST. On…
Solo un extracto — este editor licencia su texto. Lea el comunicado completo en la fuente.
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


